A successful Medical Affairs launch strategy requires every part of an organization to work in sync. For Medical Affairs, it means that by the time a product “hits” the market, most of the function will be staffed. It also means the medical field team programs will have gradually matured into a fully operational structure. Thought [...]
The Altered Pharmaceutical Thought Leader Pool: How the Implementation of the Sunshine Act and CMS Open Payment Program Changed the KOL Landscape Since the adoption of the Sunshine Act in 2010 and the subsequent thought leaders’ payments reporting on the CMS Open Payment Program in 2014, many things have changed for pharmaceutical companies. It took [...]
There’s a category of thought leader that has long been overlooked, but the data now suggests companies can no longer afford to do so—that category is the Non-MD category of Nurse Practitioners (NP) and Physician Assistants (PA). From our contacts in continuing medical education (CME), we’ve heard there has been a marked increase in the [...]
Research shows what European KOLs think of MSLs they interact with. Through the deployment of scientific field teams (MSLs), organizations’ intentions are to share medical and clinical knowledge of products with the thought leaders who in turn can spread the information to physician communities and ultimately enhance patient experiences. In the process, thought leaders become [...]
A new research study MSL Performance Metrics: Valuing the Role Throughout a Product's Lifecycle reveals key indicators on MSL performance reviews and identify the most common trends and perceptions among the medical affairs executives including how they see the 3 phases of MSL Performance Reviews. The full study presents an assessment of current practices, feedback from 37 [...]
The Instagram stars of therapeutic areas and disease management, Digital Opinion Influencers (DOIs) are a growing online presence that often can as effectively communicate and advocate for pharmaceutical solutions and products as Key Opinion Leaders (KOLs) do in more traditional channels (publications, conference presentations, perhaps even treating patients). The possibility of that very comparison makes [...]
Let's talk real world science! Leveraging real-world data and scientific evidence when making strategic decisions has never been more important—in the pharmaceutical world, at least. Though done here most convincingly, Arx Research isn’t the only research firm to notice and empirically confirm that physicians and thought leaders by and large want their discussions with pharma [...]
What KOLs think of MSLs? The good news is that everyone is doing a fairly good job! The bad news is…well there isn’t much bad news here. It seems KOLs really appreciate MSLs, maybe with just a few that don’t excel but no real bad apples! Overall ranking assessment of the quality of the relationships [...]
